Hold Alembic Pharma; target of Rs 1055: ICICI Direct
ICICI Direct recommended hold rating on Alembic Pharma with a target price of Rs 1055 in its research report dated January 20, 2021.28-01-2021
28-01-2021
ALEMBIC PHARMACEUTICALS LTD. - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
With reference to the captioned subject, this is to inform the exchange that the Company has received US Food & Drug Administration (USFDA) Final Approval for Midodrine Hydrochloride Tablets USP, 2.5 mg, 5 mg, and 10 mg. Please find enclosed herewith our press release. We request you to kindly take the same on record.22-01-2021
ALEMBIC PHARMACEUTICALS LTD. - 533573 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform the exchange that the following share certificate(s) of the Company has been reported as lost/misplaced and the registered shareholder(s) and / or their legal heir(s) of such lost share certificate have requested the Company for issue of duplicate share certificate. We enclose herewith a letter received from Link Intime India Private Limited, Registrar and Share Transfer Agent giving the proof of the date of receipt of aforesaid information by the Company.21-01-2021
ALEMBIC PHARMACEUTICALS LTD. - 533573 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform the exchange that the Company has issued Duplicate Share Certificate(s) to the following registered shareholder(s) and / or legal heir(s) of the registered shareholder(s) on 21st January, 2021. We enclose herewith an intimation received from Link Intime India Private Limited, Registrar and Share Transfer Agent giving the proof of the date of receipt of aforesaid information by the Company. We request you to kindly take the same on record.21-01-2021
Alembic Pharma extends decline on mixed December quarter results
Motilal Oswal Securities said Alembic Pharma missed Q3FY21 earnings estimate, weighed by lower-than-expected sales in the US20-01-2021
ALEMBIC PHARMACEUTICALS LTD. - 533573 - Consolidated & Standalone Unaudited Financial Results For The Quarter And Nine Months Period Ended On 31St December, 2020
With reference to the captioned matter, the exchange is hereby informed that the Board of Directors of Alembic Pharmaceuticals Limited at its meeting held today has approved the Unaudited Financial Results for the quarter and nine months period ended on 31st December, 2020. We enclose herewith the following: a) Consolidated Unaudited Financial Results for the quarter and nine months period ended on 31st December, 2020. b) Standalone Unaudited Financial Results for the quarter and nine months period ended on 31st December, 2020. c) Limited Review Report by Statutory Auditors on Consolidated as well as on Standalone Unaudited Financial Results. d) Press Release. e) Investor Presentation. The time of commencement of the Board Meeting was 11:30 a.m. and the time of conclusion was 1:00 p.m. We request you to kindly take the same on record.19-01-2021
ALEMBIC PHARMACEUTICALS LTD. - 533573 - Outcome Of Board Meeting
With reference to the captioned matter, the exchange is hereby informed that the Board of Directors of Alembic Pharmaceuticals Limited at its meeting held today has approved the Unaudited Financial Results for the quarter and nine months period ended on 31st December, 2020. We enclose herewith the following: a) Consolidated Unaudited Financial Results for the quarter and nine months period ended on 31st December, 2020. b) Standalone Unaudited Financial Results for the quarter and nine months period ended on 31st December, 2020. c) Limited Review Report by Statutory Auditors on Consolidated as well as on Standalone Unaudited Financial Results. d) Press Release. e) Investor Presentation. The time of commencement of the Board Meeting was 11:30 a.m. and the time of conclusion was 1:00 p.m. We request you to kindly take the same on record.19-01-2021
ALEMBIC PHARMACEUTICALS LTD. - 533573 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
The exchange is hereby informed that the Company will hold Post Results Conference Call on 19th January, 2021 as per the enclosed details. We request you to kindly take the same on record.12-01-2021
ALEMBIC PHARMACEUTICALS LTD. - 533573 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith a copy of Notice of Board Meeting published in English and vernacular language (Gujarati) newspaper on 8th January, 2021 in Economic Times English Edition, Indian Express English Edition and Financial Express Gujarati Edition. We request you to kindly take the same on record.08-01-2021